Findings From the Reanalysis of the NINDS Tissue Plasminogen Activator for Acute Ischemic Stroke Treatment Trial
Stroke 35:2418-2424, Ingall,T.J.,et al, 2004

Expanding the Range of Therapies for Acute Ischemic Stroke: The Early Experience of the Regional Stroke Center at Hartford Hospital
Connecticut Medicine 68:419-429, Silvernman,I.E.,et al, 2004

Multi-Section CT Angiography for Detection of Cerebral Aneurysms
AJNR 25:1485-1492, Teksam,M.,et al, 2004

Sequential Combination of Intravenous Recombinant Tissue Plasminogen Activator and Intra-Arterial Urokinase in Acute Ischemic Stroke
AJNR 25:1470-1475, Lee,K.Y.,et al, 2004

Multiple Cerebral Microbleeds:MRI Marker of a Diffuse Hemorrhage-Prone State
J Neuroimaging 14:54-57, Chalela,J.A.,et al, 2004

Fibrinogen-Depleting Agents for Acute Ischemic Stroke
Stroke 36:173-174, Liu,M.,et al, 2004

Potentially Reversible Autoimmune Limbic ncephalitis with Neuronal Potassium Channel Antibody
Neurol 62:1177-1182,1040, Thieben,M.J.,et al, 2004

Early MRI Findings in Patients Receiving Tissue Plasminogen Activator Predict Outcome: Insights into the Pathophysiology of Acute Stroke in the Thrombolysis Era
Ann Neurol 55:105-112, Chalela,J.A.,et al, 2004

Clinicopath Conf, Malignant Middle Cerebral Artery Infarction
NEJM 350:707-716, Case 5-2004, 2004

Magnetic Resonance Imaging Improves Detection of Intracerebral Hemorrhage Over Computed Tomography after Intra-Arterial Thrombolysis
Stroke 35:491-495, Greer,D.M.,et al, 2004

Relationships Between Angiographic Findings and National Institutes of Health Stroke Scale Score in Cases of Hyperacute Carotid Ischemic Stroke
AJNR 25:238-241, Nakajima,M.,et al, 2004

Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
Arch Neurol 61:346-350, Katzan,I.L.,et al, 2004

Association of Outcome with Early Stroke Treatment:Pooled Analysis of ATLANTIS, ECASS, and NINDS rt-PA Stroke Trials
Lancet 363:768-774, The ATLANTIS,ECASS,and NINDS rt-PA Study Group, 2004

Contrast Enhancement and Contrast Extravasation on Computed Tomography After Intra-Arterial Thrombolysis in Patients with Acute Ischemic Stroke
Stroke 35:876-881, Yoon,W.,et al, 2004

Combined Intravenous and Intra-Arterial Recanalization for Acute Ischemic Stroke:The Interventional Management of Stroke Study
Stroke 35:904-911, The IMS Study Investigators, 2004

Impact of Establishing a Primary Stroke Center at a Community Hospital on the Use of Thrombolytic Therapy
Stroke 34:e55, Lattimore,S.U.,et al, 2003

Perfusion-Weighted Magnetic Resonance Imaging Thresholds Identifying Core, Irreversibly Infarcted Tissue
Stroke 34:1425-1430, Shih,L.C.,et al, 2003

Major Risk Factors for Aneurysmal Subarrachnoid Hemorrhage in the Young are Modifiable
Stroke 34:1375-1381, Broderick,J.P.,et al, 2003

Arterial Thrombosis Induced by IVIg and Its Treatment with tPA
Neurol 60:1825-1826,1736, Okuda,D.,et al, 2003

Efficacy of IV Tisuse Plasminogen Activator in Acute Stroke
Neurol 61:71-75, Hsia,A.W.,et al, 2003

Trial Design and Reporting Standards for Intra-Arterial Cerebral Thrombolysis for Acute Ischemic Stroke
Stroke 34:1923-1924, Higashida,R.T.,et al, 2003

"Computed Tomography-Negative" Intracerebral Hemorrhage
Arch Neurol 60:1156-1159, Packard,A.S.,et al, 2003

Practice Parameter:Immunotherapy for Guillain-Barre Syndrome, Report of the Quality Standards Subcommittee of the American Academy of Neurology
Neurol 61:736-740, Hughes,R.A.C.,et al, 2003

Gamma Hydroxybutyrate Intoxication
NEJM 349:1267-1275, Case 30-2003, 2003

Accuracy of Contrast-Enhanced MR Angiography in Predicting Angiographic Stenosis of the Internal Carotid Artery: Linear Regression Analysis
AJNR 24:1747-1756,1737, Hathout,G.M.,et al, 2003

Combined Stent Placement and Thrombolysis in Acute Vertebrobasilar Ischemic Stroke
AJNR 24:1827-1833, Lin,D.D.M.,et al, 2003

Symmetric Deep Cerebellar Lesions After Smoking Heroin
Arch Neurol 60:1605-1606, Ropper,A.H. &Blair,R., 2003

Severe Intoxication After Phenytoin Infusion: A Preventable Pharmacogenetic Adverse Reaction
Neurol 60:1395-1396, Citerio,G.,et al, 2003

Guidelines for the Early Management of Patients with Ischemic Stroke
Stroke 34:1056-1083, Adams,H.P.,et al, 2003

Stereotactic Treatment of Intracerebral Hematoma by Means of a Plasminogen Activator
Stroke 34:968-974, Teernstra,O.P.M.,et al, 2003

Cuahoga County Operation Stroke Speed of Emergency Department Evaluation and Compliance with National Institutes of Neurological Disorders and Stroke Time Targets
Stroke 34:994-998, Katzan,I.L.,et al, 2003

Use of a Field-to-Stroke Center Helicopter Transport Program to Extend Thrombolytic Therapy to Rural Residents
Stroke 34:729, Silliman,S.L.,et al, 2003

Telemedicine for Acute Stroke
Stroke 34:725, LaMonte,M.P.,et al, 2003

Early Major Ischemic Changes on Computed Tomography Should Preclude Use of Tissue Plaminogen Activator
Stroke 34:820-821,822, von Kummer,R., 2003

Early Major Ischemic Changes on Computed Tomography Should Not Preclude Use of Tissue Plasminogen Activator
Stroke 34:821-822,822, Lyden,P.,et al, 2003

Management of Drug and Alcohol Withdrawal
NEJM 348:1786-1795, Kosten,T.R. &O'Connor,P.G., 2003

Frequency of Thrombolytic Therapy in Patients With Acute Ischemic Stroke and the Risk of In-Hospital Mortality
Stroke 34:1106-1113, Heuschmann,P.U.,et al, 2003

Pre- and In-Hospital Delays From Stroke Onset to Intra-arterial Thrombolysis
Stroke 34:1230-1234, Nedeltchev,K.,et al, 2003

Effects of Admission Hyperglycemia on Stroke Outcome in Reperfused Tissue Plasminogen Activator-Treated Patients
Stroke 34:1235-1241, Alvarez-Sabin,J.,et al, 2003

Hemi-orolingual Angioedema and ACE Inhibition After Alteplase Treatment of Stroke
Neurol 60:1525-1527,1403, Hill,M.D.,et al, 2003

Prospective Evaluation of Carotid Artery Stenosis: Elliptic Centric Contrast-Enhanced MR Angiography and Spiral CT Angiography Compared with Digital Subtraction Angiography
AJNR 24:1012-1019, Alvarez-Linera,J.,et al, 2003

Immediate Reocclusion Following a Successful Thrombolysis in Acute Stroke: A Pilot Study
Neurol 60:1684-1687, Heo,J.H.,et al, 2003

Intra-arterial Thrombolysis in 24 Consecutive Patients with Internal Carotid Artery T Occlusions
JNNP 74:739-742, Arnold,M.,et al, 2003

Preoperative Evaluation of Carotid Artery Stenosis: Comparison of Contrast-Enhanced MR Angiography and Duplex Sonography with Digital Subtraction Angiography
AJNR 24:1117-1122, Borisch,I.,et al, 2003

Are Some Patients Likely to Benefit From Recombinant Tissue-Type Plasminogen Activator for Acute Ischemic Stroke Even Beyond 3 Hours From Symptom Onset?
Stroke 34:464-467, Kent,D.M.,et al, 2003

Imaging-Based Decision Making in Thrombolytic Therapy for Ischemic Stroke
Stroke 34:575-583, Schellinger,P.D.,et al, 2003

Clinicopath Conf., Chronic Inflammatory Demyelinating Polyneuropathy
NEJM 348:735-743, Case 6-2003, 2003

Treatment of Autoimmune Myasthenia Gravis
Neurol 61:1652-1661, Richman,D.P. & Agius,M.A., 2003

Tissue Plasminogen Activator for Acute Ischemic Stroke in Clinical Practice
Stroke 34:2847-2850, Graham,G.D., 2003

Infective Endocarditis in Dialysis Patients: New Challenges and Old
Kidney Int 64:720-727, Doulton, T.,et al, 2003